The research firm Zacks upgraded InnovAge (INNV) to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company’s earnings prospects. This upgrade follows evidence of improving financial performance and positions InnovAge favorably among healthcare services stocks. Analysts cited the firm’s proven cost-control measures within its Program of All-Inclusive Care for the Elderly (PACE) model and its expanding participant base as key drivers of the positive outlook.

In its Q2 2026 report, InnovAge posted earnings of $0.08 per share, surpassing the Zacks Consensus Estimate of $0.04 and reversing a loss of $0.10 per share in the same quarter a year ago. Revenues grew year-over-year, driven by a 12% increase in average participants to approximately 8,010 across 20 centers in six states as of December 31, 2025. Management attributed the margin improvement to reduced hospital utilization and streamlined care coordination.

On February 5, 2026, InnovAge representatives and enrolled seniors met with Colorado lawmakers at the State Capitol to showcase PACE outcomes. Attendees shared data demonstrating 25% lower hospitalization rates and 30% fewer emergency room visits compared to standard Medicare populations. Senior Vice President of Government Affairs Don Nelson emphasized the model’s cost-effectiveness for taxpayers, while Lt. Gov. Dianne Primavera and House Majority Leader Monica Duran voiced support for policies that protect Medicaid funding and expand home- and community-based care.